Neurodevelopment at 11 months after starting antiretroviral therapy within 3 weeks of life

Southern African Journal of HIV Medicine

 
 
Field Value
 
Title Neurodevelopment at 11 months after starting antiretroviral therapy within 3 weeks of life
 
Creator Laughton, Barbara Naidoo, Shalena Dobbels, Els F.M.T. Boivin, Michael J. Janse van Rensburg, Anita Glashoff, Richard H. van Zyl, Gert U. Kruger, Mariana Cotton, Mark F.
 
Subject Health; Paediatrics; Psychology HIV; Infants; Antiretroviral Therapy; neurodevelopen; Paediatricst
Description Background: Antiretroviral therapy (ART) started between 7 and 12 weeks of age improves neurodevelopmental outcomes in HIV-infected (HIV+) infants, but the impact of even earlier initiation is not yet described.Objective:  We assessed the early neurodevelopment of HIV+ infants who started ART within 21 days of life. Methods: Participants were enrolled from the public sector birth HIV-diagnosis program. Inclusion criteria included: birth weight 2000g, infant commencing ART 6 weeks and no infant Cytomegalovirus disease. ART included Zidovudine/Lamivudine/Nevirapine for the first 2 weeks, the latter then replaced by Lopinavir/Ritonavir. Once body weight 3kg and gestational age 44 weeks, Abacavir replaced Zidovudine. The Griffiths Mental Development Scales (GMDS) were administered at 10-12 months.Results: Of 29 infants assessed, 23 (79%) were girls. Mean birth weight was 3002 ± 501g. Twenty-four mothers (83%) received ART during pregnancy. Seven (24%) infants were diagnosed HIV+ within 48 hours of birth. Median [IQR] viral load (VL) at diagnosis was 3904 [259;16922] copies/ml, age starting ART was 6.0 [3;10] days and age at VL suppression was 19.1 [15; 36] weeks. At the GMDS assessment nine (31%) participants had detectable VL and 26 (90%) had WHO clinical stage I disease. GMDS was performed at a mean age of 11.5±0.8 months. Mean quotients were within the average range: Global Griffiths score was 103.6±10.9 and mean quotients on the subscales ranged from lowest 95.9±13.4 for Locomotor to highest 112.8±11.3 for Hearing-and-language.Conclusion: Preliminary findings in this small group suggest that early neurodevelopmental scores are within the normal range in infants with perinatal HIV-infection who started ART at a median of 6 days.
 
Publisher AOSIS
 
Contributor National Institute of Mental Health of the National Institutes of Health
Date 2019-10-30
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion — Descriptive preliminary sample
Format text/html application/epub+zip text/xml application/pdf
Identifier 10.4102/sajhivmed.v20i1.1008
 
Source Southern African Journal of HIV Medicine; Vol 20, No 1 (2019); 8 pages 2078-6751 1608-9693
 
Language eng
 
Relation
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:

https://sajhivmed.org.za/index.php/hivmed/article/view/1008/1693 https://sajhivmed.org.za/index.php/hivmed/article/view/1008/1692 https://sajhivmed.org.za/index.php/hivmed/article/view/1008/1694 https://sajhivmed.org.za/index.php/hivmed/article/view/1008/1691
 
Coverage South Africa Infants 11 months old, HIV-infected
Rights Copyright (c) 2019 Barbara Laughton, Shalena Naidoo, Els Francoise Marie-Therese Dobbels, Michael Joseph Boivin, Anita Janse van Rensburg, Richard Helmuth Glashoff, Gert Uves van Zyl, Mariana Kruger, Mark Fredric Cotton https://creativecommons.org/licenses/by/4.0
ADVERTISEMENT